Baggio et al., Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans, Nat
Published online March 24, 2022
Why Long-Term Risks Are Still Uncertain GLP-1 drugs are relatively new, and large-scale studies have primarily focused on: 612 month use diabetes-specific outcomes cardiovascular risk reduction What we dont have yet: long-term (515 year) safety data long-term pancreatic outcome studies long-term GI motility tracking full population data on chronic or permanent side effects long-term cancer risk data Large numbers of patients now take GLP-1 drugs indefinitely , especially for weight loss
What is an NAD+ Supplement
A Randomized, Double-blind, Placebo-controlled Clinical Study to Investigate the efficacy of Herring Roe Oil for treatment of Psoriasis
Dosing Protocol The FDA-approved daily dosing approach, with an optional tolerability titration